The International Journal of Tuberculosis and Lung Disease

Progress in the development of new vaccines against tuberculosis [Leading Article]
pp. 95-100(6)
Author: Orme, Ian M.

Review of published cost-effectiveness studies on tuberculosis treatment programmes
pp. 101-109(9)
Author: Fryatt, R. J.

Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995
pp. 110-114(5)
Authors: Bercion, R.; Kuaban, C.

A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York
pp. 115-121(7)
Authors: Moss, A. R.; Alland, D.; Telzak, E.; Hewlett Jr., D.; Sharp, V.; Chiliade, P.; LaBombardi, V.; Kabus, D.; Hanna, B.; Palumbo, L.; Brudney, K.; Weltman, A.; Stoeckle, K.; Chirgwin, K.; Simberkoff, M.; Moghazeh, S.; Eisner, W.; Lutfey, M.; Kreiswirth, B.

Effect of human newborn BCG immunization on monocyte viability and function at 3 months of age
pp. 122-127(6)
Authors: Sepulveda, R. L.; Arredondo, S.; Rodriguez, E.; Gonzalez, B.; Leiva, L. E.; Sorensen, R. U.

Two-step tuberculin skin testing of injection drug users recruited from community-based settings
pp. 128-134(7)
Authors: Lifson, A. R.; Grant, S. M.; Lorvick, J.; Pinto, F. D.; He, H.; Thompson, S.; Keudell, E. G.; Stark, M. J.; Booth, R. E.; Watters, J. K.

Missed opportunities for prevention of tuberculosis in Victoria, Australia
pp. 135-141(7)
Authors: MacIntyre, C. R.; Plant, A. J.; Yung, A.; Streeton, J. A.

The tuberculosis program of Catalonia's central health region (1986–1993)
pp. 142-146(5)
Authors: Miret-Cuadras, P.; Gonzalez-Fernandez, P.; Lopez-Sanmartin, J. L.; Martin-Ramos, A.; Pina Gutierrez, J. M.

Does pulmonary tuberculosis change with ageing?
pp. 147-151(5)
Authors: Rocha, M.; Pereira, S.; Barros, H.; Seabra, J.

Short-course chemotherapy in the treatment of Pott's paraplegia: report on five year follow-up
pp. 152-158(7)
Authors: Rajeswari, R.; Balasubramanian, R.; Venkatesan, P.; Sivasubramanian, S.; Soundarapandian, S.; Shanmugasundaram, T. K.; Prabhakar, R.

Extra-pulmonary tuberculosis: a high frequency in the absence of HIV infection
pp. 159-162(4)
Authors: Cowie, R. L.; Sharpe, J. W.

A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements
pp. 163-169(7)
Authors: Burman, W. J.; Reves, R. R.; Rietmeijer, C. A.; Cohn, D. L.

Association between an early humoral response to Mycobacterium tuberculosis antigens and later development of tuberculosis in human immunodeficiency virus-infected individuals
pp. 170-174(5)
Authors: Cavalcante, S.; Kritski, A. L.; Ferreira, M. A. S.; Souza, M. A.; Laszlo, A.; Werneck-Barroso, E. B.; Fonseca, L. S.

Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis
pp. 175-180(6)
Authors: Immanuel, C.; Swamy, R.; Kannapiran, M.; Vijayalakshmi, S.; Sundaram, V.; Jagannath, K.; Paramasivan, C. N.

Shared vision—a health education project designed to enhance adherence to anti-tuberculosis treatment [Planning and Practice]
pp. 181-186(6)
Authors: Dick, J.; Lombard, C.

Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis [Case Study]
pp. 187-190(4)
Authors: Akula, S. K.; Aruna, A. S.; Johnson, J. E.; Anderson, D. S.

Correspondence
pp. 191-192(2)